We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
-1.37%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$196M
AUM Growth
-$3.16M
Cap. Flow
+$648K
Cap. Flow %
0.33%
Top 10 Hldgs %
25.13%
Holding
97
New
Increased
34
Reduced
26
Closed
2

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$2.12M
2
PG icon
Procter & Gamble
PG
+$434K
3
IBB icon
iShares Biotechnology ETF
IBB
+$394K
4
XOM icon
ExxonMobil
XOM
+$342K
5
GE icon
GE Aerospace
GE
+$326K

Sector Composition

Rank Sector Weight
1 Technology 14.47%
2 Industrials 14.39%
3 Healthcare 11.95%
4 Financials 11.2%
5 Consumer Staples 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OIH icon
51
VanEck Oil Services ETF
OIH
$2.06B
$1.47M 0.75%
3,078
+333
+12% +$172K
IAU icon
52
iShares Gold Trust
IAU
$62.9B
$1.2M 0.61%
47,280
+10,725
+29% +$274K
JNJ icon
53
Johnson & Johnson
JNJ
$618B
$1.2M 0.61%
9,355
-450
-5% -$60.8K
T icon
54
AT&T
T
$159B
$1.15M 0.59%
42,653
-4,537
-10% -$126K
AMJ
55
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$1.13M 0.58%
47,080
+8,130
+21% +$223K
CVX icon
56
Chevron
CVX
$392B
$1.09M 0.56%
9,592
GOOG icon
57
Alphabet (Google) Class C
GOOG
$4.36T
$999K 0.51%
19,380
-1,860
-9% -$103K
JPM icon
58
JPMorgan Chase
JPM
$935B
$973K 0.5%
8,853
CTAS icon
59
Cintas
CTAS
$81.9B
$943K 0.48%
22,120
IBB icon
60
iShares Biotechnology ETF
IBB
$9.34B
$908K 0.46%
8,514
+3,555
+72% +$394K
DIS icon
61
Walt Disney
DIS
$167B
$742K 0.38%
7,391
SYK icon
62
Stryker
SYK
$125B
$729K 0.37%
4,534
PFE icon
63
Pfizer
PFE
$143B
$715K 0.36%
21,261
AOR icon
64
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.66B
$695K 0.35%
15,612
-340
-2% -$15.4K
DUK icon
65
Duke Energy
DUK
$97.8B
$651K 0.33%
8,407
IBM icon
66
IBM
IBM
$211B
$616K 0.31%
4,203
-523
-11% -$79.1K
BXP icon
67
Boston Properties
BXP
$11.2B
$597K 0.3%
4,850
NEE icon
68
NextEra Energy
NEE
$181B
$594K 0.3%
14,560
VEU icon
69
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
$581K 0.3%
10,699
SYY icon
70
Sysco
SYY
$40.8B
$516K 0.26%
8,620
BA icon
71
Boeing
BA
$171B
$515K 0.26%
1,571
BMY icon
72
Bristol-Myers Squibb
BMY
$133B
$501K 0.26%
7,930
CAT icon
73
Caterpillar
CAT
$375B
$483K 0.25%
3,282
-50
-2% -$7.89K
PAYX icon
74
Paychex
PAYX
$41.6B
$477K 0.24%
7,755
ORCL icon
75
Oracle
ORCL
$374B
$435K 0.22%
9,510

Similar funds

Boston Research & Management's Q1 2018 Portfolio in Review

As of Q1 2018, Boston Research & Management held 97 positions worth $196M, down 1.6% from $199M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q1 2018: portfolio turnover was 2.1%. Boston Research & Management opened no new positions and exited 2, leaving the 97-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Industrials and Healthcare.

  • Boston Research & Management added most to Merck in Q1 2018, an estimated $2.12M increase.
  • Boston Research & Management's biggest Q1 2018 reduction was Wells Fargo, cutting an estimated $2.87M.
  • Boston Research & Management fully exited Union Pacific in Q1 2018, selling an estimated $351K.
  • Boston Research & Management's ten largest holdings make up 25% of its $196M portfolio in Q1 2018.
  • Boston Research & Management opened 0 new positions and closed 2 in Q1 2018.
  • Boston Research & Management's portfolio value fell 1.6% quarter-over-quarter to $196M.

Based on Boston Research & Management's 13F filing for Q1 2018, filed 9 May 2018.